Portfolio company
Intercytex Group
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops regenerative medicine products and cell-based therapies for patients with skin damage, chronic wounds and hair loss.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aurealis Pharma
This company develops cell and gene therapies for patients suffering from chronic wounds, cancer and inflammatory diseases.
Pelage
This company develops regenerative topical medicines to treat hair loss for individuals with androgenetic alopecia and other forms of hair thinning.
MyoPax
This company develops muscle regeneration cell and gene therapies for patients with congenital malformations, trauma, hereditary dystrophies and muscle wasting disorders.
Stemore
This biotechnology company develops stem cell therapies and antibody treatments for hair loss and skin regeneration targeting medical patients and pharmaceutical partners.
VascVersa Ltd
This company develops vascular cell therapies to regenerate blood vessels for patients with ischaemic diseases, chronic wounds, and retinal vascular conditions.
VERITACELL
This company produces surgical kits for point-of-care skin cell isolation and regeneration to help surgeons and hospitals treat patient wounds and scarring.
Castle Creek Biosciences
This company develops cell and gene therapies for patients suffering from rare genetic skin and connective tissue diseases.
ReproGo
This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.
